229 related articles for article (PubMed ID: 1688295)
1. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
Kletzel M; Beck S; Elser J; Shock N; Burks W
Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
[TBL] [Abstract][Full Text] [Related]
2. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
[TBL] [Abstract][Full Text] [Related]
3. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
[TBL] [Abstract][Full Text] [Related]
4. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
[No Abstract] [Full Text] [Related]
5. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients.
Absar N; Daneshvar H; Beall G
J Allergy Clin Immunol; 1994 Jun; 93(6):1001-5. PubMed ID: 8006304
[TBL] [Abstract][Full Text] [Related]
6. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ.
Gluckstein D; Ruskin J
Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulphamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
Dis Markers; 1991; 9(6):355. PubMed ID: 1823331
[No Abstract] [Full Text] [Related]
8. Trimethoprim-sulfamethoxazole desensitization in AIDS.
Papakonstantinou G; Füessl H; Hehlmann R
Klin Wochenschr; 1988 Apr; 66(8):351-3. PubMed ID: 3260637
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1.
Rigaud M; Pollack H; Leibovitz E; Kim M; Persaud D; Kaul A; Lawrence R; John DD; Borkowsky W; Krasinski K
J Pediatr; 1994 Sep; 125(3):476-80. PubMed ID: 7915306
[TBL] [Abstract][Full Text] [Related]
10. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
11. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
Cook DE; Kossey JL
Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
[TBL] [Abstract][Full Text] [Related]
12. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
[No Abstract] [Full Text] [Related]
13. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.
Carr A; Swanson C; Penny R; Cooper DA
J Infect Dis; 1993 Jan; 167(1):180-5. PubMed ID: 8380290
[TBL] [Abstract][Full Text] [Related]
15. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients.
Nguyen MT; Weiss PJ; Wallace MR
AIDS; 1995 Jun; 9(6):573-5. PubMed ID: 7662195
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Kovacs JA; Masur H
Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
[TBL] [Abstract][Full Text] [Related]
17. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
Jung AC; Paauw DS
Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835
[TBL] [Abstract][Full Text] [Related]
18. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus.
Martin GJ; Paparello SF; Decker CF
Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303
[No Abstract] [Full Text] [Related]
19. Cutaneous adverse reactions and CD4+ cell counts in human immunodeficiency virus-infected patients receiving trimethoprim-sulfamethoxazole.
Caumes E
Clin Infect Dis; 1998 Feb; 26(2):530-2. PubMed ID: 9502502
[No Abstract] [Full Text] [Related]
20. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
Belchi-Hernandez J; Espinosa-Parra FJ
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]